Skip to main content
SleepCited

Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.

Galia V Anguelova, Monique H M Vlak, Arthur G Y Kurvers, Roselyne M Rijsman
Review Sleep medicine clinics 2018 21 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D29759272'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
Patients with primary RLS
Intervention
Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome. None
Vergleichsgruppe
None
Primärer Endpunkt
RLS symptom control
Wirkungsrichtung
Mixed
Verzerrungsrisiko
Unclear

Abstract

This article provides an updated practical guide for the treatment of primary restless legs syndrome (RLS). Articles that appeared after the American Academy of Neurology guideline search were reviewed according to the same evidence rating schedule. We found limited evidence for nonpharmacologic treatment options. In moderate to severe primary RLS, pharmacologic options may be considered, including iron suppletion, an α2δ ligand, a dopamine agonist, a combination of an α2δ ligand and a dopamine agonist, or oxycodone/naloxone. This article includes treatment options in case of augmentation.

Zusammenfassung

This article provides an updated practical guide for the treatment of primary restless legs syndrome and includes treatment options in case of augmentation.

Used In Evidence Reviews

Similar Papers